An educational nursing program can positively impact medication compliance in patients receiving oral pulmonary arterial hypertension (PAH) therapies.
An educational nursing program can positively impact medication compliance in patients receiving oral pulmonary arterial hypertension (PAH) therapies, according to research presented at AMCP 2021, the annual meeting of the Academy of Managed Care Pharmacy, held virtually April 12-16.
PAH therapies do not reverse, halt, or cure the chronic disease. Instead, they improve pulmonary hemodynamics and offer symptom relief. However, because medication tolerance and compliance are a challenge, health care providers can play a role in improving adherence.
“In-home nurse visits offer disease state education, discuss therapy expectations, and provide support tools for patients when experiencing adverse events that might lead to therapy discontinuation,” the researchers explained.
They evaluated the impact of in-home or face-to-face education visits on oral PAH therapy compliance by comparing patients who were supported by a nursing program with patients who were not.
The researchers used CVS Health pharmacy claims to identify 2 groups: the study group was patients (n = 197) on riociguat, selexipag, or treprostinil who were supported by a nursing program and the control group was patients (n = 213) on bosentan, ambrisentan, or macitentan who were not supported by a nursing program. All therapies were oral PAH therapies and the study claims covered January 2018 to June 2019.
The study compared the following between the 2 groups:
The study accounted for demographic and medication factors associated with adherence using a generalized linear model and logistic regression.
After 6 months, the study found patients in the study group:
Patients in the control group were 1.5 times more likely to drop their therapy in the first 6 months.
According to the authors, the significant improvement in MPR and therapy persistence highlighted the success of the educational nursing program in improving overall medication compliance to oral PAH therapies.
“While our study compared two different PAH therapy classes, a multidisciplinary patient support approach contributed to improved patient outcomes,” the authors concluded.
References
Sourounis E, Kyrychenko P, Avalos-Reyes E, Bagford D, Grover R, Feczko L. Effects of face-to-face educational nursing support on patient compliance with oral PAH therapies. Presented at: AMCP 2021; April 12-16, 2021. Abstract I6.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More